Gide Health review

Gide may appeal to someone comparing several treatment types through one platform. Before paying, get the actual preparation, dispensing pharmacy, full charge and state eligibility in writing: the public pages contain inconsistencies that prevent a confident apples-to-apples price comparison.

Gide Health is an online platform offering access to licensed providers for prescription care. Its terms say that it does not practice medicine directly and identify Beluga Health as a network partner. That names a network relationship, rather than the specific medical practice or clinician who would handle your care. Ask for those names before treatment, along with the pharmacy that would dispense your prescription.

The public menu spans weight management, NAD+, sermorelin, glutathione, hormonal treatments and hair-loss tablets. Some homepage copy still describes hormone care as coming soon, although dedicated product pages list it. Treat those as public listings that need an availability check, rather than a guarantee that every program can be prescribed in your state.

The advertised process starts with an online assessment, followed by clinician review and shipment if treatment is prescribed. The homepage describes made-to-order prescriptions and ongoing care-team support without an extra charge. The FAQ says the plan includes the doctor’s visit, medication and free shipping, but the same paragraph unexpectedly refers to “Eden.” Confirm which services belong to your selected Gide program, particularly whether any testing or follow-up costs extra.

The terms require users to be at least 18. State coverage is less clear: the terms exclude Mississippi, New Mexico and Louisiana, while the GLP-1 FAQ also excludes Arkansas. A separate pharmacy paragraph names F&F Pharmacies Inc, doing business as Jungle Jim’s Pharmacy, and says it serves 44 states while listing ten states where it lacks a license. It also says that pharmacy cannot dispense sterile compounds. These statements do not settle where a particular injection would be filled or shipped. Ask for the actual pharmacy and its eligibility for your state and preparation; a general provider-network claim does not answer that question.

The GLP-1 pages advertise starting prices of $149 per month for drops, $209 for the standard injection and $299 for the advanced injection. These figures do not establish a selected prescription’s dose, supply, first payment, full term cost or renewal amount. The checked public terms do not define whether “month” means a calendar month or a shorter billing cycle. Get a complete payment schedule rather than assuming the headline figure is the amount charged each month.

Other advertised starting prices include NAD+ injection at $183 per month, NAD+ nasal spray at $159, sermorelin injection at $159, sermorelin troches at $133, glutathione injection at $99 and glutathione nasal spray at $149. These remain product advertisements, rather than verified recurring quotes. Comparing the lowest banner across programs would mix different medicines, formats and undisclosed supplies.

The hormone category page advertises enclomiphene tablets at $149 per month and progesterone tablets at $39 per month, each explicitly “on a 6-month plan.” Both men’s and women’s hair-loss tablet cards advertise $133 per month with the same six-month-plan qualifier. That states the advertised plan length; it does not establish whether the full amount is paid upfront, paid in installments or renewed automatically. The product pages also describe enclomiphene with tadalafil and estradiol formats, but these card terms should not be extended to those products or other programs. A low price for one named medicine does not establish the cost of a broader hormone or longevity plan.

The terms say all purchases are final and that refunds are unavailable once services have started or a prescription has been sent to the pharmacy. They do not establish a subscription cancellation deadline or recurring billing cadence. Obtain the rules for stopping future charges and the cost of any already-started consultation before enrolling.

The homepage explicitly describes compounded semaglutide or tirzepatide injections. The standard injection and oral-drops pages name semaglutide, but the advanced injection page describes dual-pathway action while also displaying a semaglutide label. Do not assume that “advanced” establishes tirzepatide or a particular combination. The drops page adds another conflict: it describes a daily oral option but carries an FAQ about weekly injections. Ask the prescriber to identify the exact active ingredient, preparation and instructions.

The longevity pages list NAD+ injections and nasal spray, sermorelin injections and dissolvable troches, and glutathione injections and nasal spray. Their individual branded or compounded status is not established merely by a general reference to compounding pharmacies. The observed tesamorelin menu link returned a missing page, so it does not establish a current offering.

The men’s hormone products are enclomiphene-based; that is not a testosterone-replacement listing. The hair pages explicitly call their products compounded tablets. The men’s tablet lists minoxidil, finasteride, biotin and vitamin E; the women’s version omits finasteride. Ingredient lists and seller testimonials do not independently establish suitability, safety or results. Discuss the actual prescription and its evidence with the treating clinician.